| Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China RL Kruse F1000Research 9, 2020 | 391 | 2020 |
| Constitutive signaling from an engineered IL7 receptor promotes durable tumor elimination by tumor-redirected T cells T Shum, B Omer, H Tashiro, RL Kruse, DL Wagner, K Parikh, Z Yi, ... Cancer discovery 7 (11), 1238-1247, 2017 | 260 | 2017 |
| Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus‐infected patients RL Kruse, JR Kramer, GL Tyson, Z Duan, L Chen, HB El‐Serag, F Kanwal Hepatology 60 (6), 1871-1878, 2014 | 94 | 2014 |
| HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric mice RL Kruse, T Shum, H Tashiro, M Barzi, Z Yi, C Whitten-Bauer, X Legras, ... Cytotherapy 20 (5), 697-705, 2018 | 88 | 2018 |
| Diagnosis and management of pulmonary infection due to Rhodococcus equi WV Lin, RL Kruse, K Yang, DM Musher Clinical Microbiology and Infection 25 (3), 310-315, 2019 | 69 | 2019 |
| Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model B Bissig-Choisat, L Wang, X Legras, PK Saha, L Chen, P Bell, ... Nature communications 6 (1), 7339, 2015 | 66 | 2015 |
| In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides G Billioud, RL Kruse, M Carrillo, C Whitten-Bauer, D Gao, A Kim, L Chen, ... Journal of Hepatology 64 (4), 781-789, 2016 | 63 | 2016 |
| Corynebacteria as a cause of pulmonary infection: a case series and literature review K Yang, RL Kruse, WV Lin, DM Musher Pneumonia 10, 1-8, 2018 | 54 | 2018 |
| Wilson disease: update on pathophysiology and treatment S Dev, RL Kruse, JP Hamilton, S Lutsenko Frontiers in cell and developmental biology 10, 871877, 2022 | 38 | 2022 |
| Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities T Shum, RL Kruse, CM Rooney Expert opinion on biological therapy 18 (6), 653-664, 2018 | 36 | 2018 |
| Drug Repurposing to treat Asthma and Allergic Disorders: Progress and Prospects. RL Kruse, K Vanijcharoenkarn Allergy, 2017 | 23 | 2017 |
| Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. F1000Res. 2020; 9: 72 RL Kruse Epub 2020/01/31. doi: 10.12688/f1000research. 22211.2. PubMed PMID: 32117569, 0 | 20 | |
| A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2 RL Kruse, Y Huang, H Smetana, EA Gehrie, TK Amukele, AAR Tobian, ... Biochemical and biophysical research communications 553, 165-171, 2021 | 18 | 2021 |
| Isohemagglutinin titering performed on an automated solid‐phase and hemagglutinin‐based analyzer is comparable to results obtained by manual gel testing K Lally, RL Kruse, H Smetana, R Davis, A Roots, C Marshall, PM Ness, ... Transfusion 60 (3), 628-636, 2020 | 18 | 2020 |
| In situ liver expression of HBsAg/CD3-bispecific antibodies for HBV immunotherapy RL Kruse, T Shum, X Legras, M Barzi, FP Pankowicz, S Gottschalk, ... Molecular therapy Methods & clinical development 7, 32-41, 2017 | 18 | 2017 |
| Intracellular translation of circular RNA R Kruse US Patent 9,822,378, 2017 | 12 | 2017 |
| Therapeutic plasma exchange for the treatment of refractory necrotizing autoimmune myopathy RL Kruse, J Albayda, SO Vozniak, CE Lawrence, R Goel, ... Journal of Clinical Apheresis 37 (3), 253-262, 2022 | 10 | 2022 |
| Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. F1000Research. 2020; 9: 72 RL Kruse | 10 | 2020 |
| Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection RL Kruse, X Legras, M Barzi Virus research 292, 198224, 2021 | 8 | 2021 |
| A hemagglutination-based semiquantitative test for point-of-care determination of SARS-CoV-2 antibody levels RL Kruse, Y Huang, A Lee, X Zhu, R Shrestha, O Laeyendecker, ... Journal of clinical microbiology 59 (12), 10.1128/jcm. 01186-21, 2021 | 7 | 2021 |
Thomas ShumThe Brigham and Women's Hospital, Harvard Medical SchoolVerified email at bwh.harvard.edu
